Average cost of multi drug-resistant tuberculosis treatment in Iran, Islamic Republic of
Iran, Islamic Republic of: Average cost of multi drug-resistant tuberculosis treatment was 28,730 constant 2022 US$ in 2022. ◆ Volatile
Latest (2022)
28,730 constant 2022 US$
Change on year
unchanged
World rank
3rd
of 92 countries
All-time high
28,730 constant 2022 US$
in 2021
All-time low
1,827 constant 2022 US$
in 2018
Years of data
6
2017–2022
Average cost of multi drug-resistant tuberculosis treatment in Iran, Islamic Republic of, 2017–2022
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2022, average cost of multi drug-resistant tuberculosis treatment in Iran, Islamic Republic of stood at 28,730 constant 2022 US$. That is the highest value across all 6 years on record.
The figure is up 834.6% over ten years.
That places Iran, Islamic Republic of 3rd out of 92 countries with data for 2022, putting it in the top 10%.
Average cost of multi drug-resistant tuberculosis treatment in Iran, Islamic Republic of, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 3,074 constant 2022 US$ | — |
| 2018 | 1,827 constant 2022 US$ | -40.6% |
| 2019 | 21,626 constant 2022 US$ | +1083.7% |
| 2020 | 4,600 constant 2022 US$ | -78.7% |
| 2021 | 28,730 constant 2022 US$ | +524.6% |
| 2022 | 28,730 constant 2022 US$ | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 8,842 constant 2022 US$ | 1,827 constant 2022 US$ | 21,626 constant 2022 US$ | 3 |
| 2020s | 20,687 constant 2022 US$ | 4,600 constant 2022 US$ | 28,730 constant 2022 US$ | 3 |
Countries ranked near Iran, Islamic Republic of
More health data for Iran, Islamic Republic of
- Un projection of annual infant deaths, annual growth rate -1.38 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5627 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,361 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,070 deaths (2100)
- Population ages 75-79, female, annual growth rate 8.59 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0081 units per person (2025)
- Population ages 75-79, male, annual growth rate 9.67 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.0077 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Iran, Islamic Republic of?
- Average cost of multi drug-resistant tuberculosis treatment in Iran, Islamic Republic of was 28,730 constant 2022 US$ in 2022, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Iran, Islamic Republic of?
- The highest recorded value was 28,730 constant 2022 US$ in 2021.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Iran, Islamic Republic of?
- The lowest recorded value was 1,827 constant 2022 US$ in 2018.
- How does Iran, Islamic Republic of rank for average cost of multi drug-resistant tuberculosis treatment?
- Iran, Islamic Republic of ranks 3rd out of 92 countries with data for 2022.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Iran, Islamic Republic of?
- Over the last ten years it is up 834.6%. The long-run trend across the full record is volatile.
- Where does this Iran, Islamic Republic of data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.